Streetbeat News

Products Services

TNXP

Tonix Pharmaceuticals has partnered with Bilthoven Biologicals, part of the Cyrus Poonawalla Group, to advance TNX-801, an Mpox vaccine candidate. This collaboration aims to leverage the expertise of the world's largest vaccine manufacturer.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:10 am

OCGN

Ocugen, Inc. has received approval from Health Canada to begin a Phase 3 clinical trial for its gene therapy product, OCU400, aimed at treating retinitis pigmentosa.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:09 am

REGN

Regeneron has received approval from the European Commission for Ordspono, a bispecific antibody, to treat adult patients with relapsed or refractory follicular lymphoma or diffuse large B-cell lymphoma after two or more lines of systemic therapy. This is the first regulatory approval for Ordspono globally, based on successful Phase 1 and Phase 2 trials.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:09 am

NRDY

Wapakoneta City Schools has partnered with Nerdy Company, specifically Varsity Tutors for Schools, to provide live and on-demand tutoring resources. This partnership will last until June 30, 2030, offering extensive educational resources for students, educators, and parents.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:06 am

GOGO

Gogo Business Aviation has partnered with Skyservice to develop FAA and TCCA Supplemental Type Certificates for Gogo 5G on six aircraft models.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:06 am

AAPL

GLD

NVDA

SPY

TSLA

U.S. stocks closed higher as Fed Chair Jerome Powell hinted at a potential rate cut in September, boosting major indexes like the S&P 500, Dow Jones, and Nasdaq. Financial stocks reached an all-time high, and all 11 major sectors of the S&P 500 ended in positive territory. Oil prices rose due to geopolitical tensions, while gold hit a record high as the dollar weakened.

Portfolio Pulse from Akanksha Bakshi

August 26, 2024 | 11:05 am

BMY

Bristol Myers Squibb will present new research findings on its cardiovascular treatments, including CAMZYOS, ELIQUIS, and Milvexian, at the ESC Congress in London. The data includes long-term efficacy and safety results for CAMZYOS and collaborations with Pfizer and Johnson & Johnson.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 11:01 am

MRK

The European Commission has approved Merck's Winrevair (Sotatercept) for use in combination with other therapies to treat pulmonary arterial hypertension (PAH) in adult patients. This approval is aimed at improving exercise capacity in patients with WHO Functional Class II to III PAH.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 10:49 am

DQ

Daqo New Energy anticipates producing 43,000MT-46,000MT of polysilicon in Q3 FY24 and 210,000MT-220,000MT in 2024, indicating a strong production outlook.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 10:40 am

FDX

META

FedEx has integrated WhatsApp notifications into its e-commerce delivery solution for consumers in Saudi Arabia, enhancing its FedEx Delivery Manager International service. This allows recipients to receive delivery notifications and interact with FedEx via a META-verified WhatsApp business account, reducing online risks.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 10:34 am